Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment
Samuel A. Kerk, Thales Papagiannakopoulos, Yatrik M. Shah, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 8, pp. 510-525
Open Access | Times Cited: 153

Showing 1-25 of 153 citing articles:

KRAS mutation: from undruggable to druggable in cancer
Lamei Huang, Zhixing Guo, Fang Wang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 585
Lineage tracing reveals the phylodynamics, plasticity, and paths of tumor evolution
Dian Yang, Matthew G. Jones, Santiago Naranjo, et al.
Cell (2022) Vol. 185, Iss. 11, pp. 1905-1923.e25
Open Access | Times Cited: 217
Non-Small-Cell Lung Cancer in 2022: A Review for General Practitioners in Oncology
Hamid Mithoowani, Michela Febbraro
Current Oncology (2022) Vol. 29, Iss. 3, pp. 1828-1839
Open Access | Times Cited: 175
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Yue Zhou, Lei Tao, Jiahao Qiu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 126
Glutaminase inhibition impairs CD8 T cell activation in STK11-/Lkb1-deficient lung cancer
Sarah A. Best, Patrick M. Gubser, Shalini Sethumadhavan, et al.
Cell Metabolism (2022) Vol. 34, Iss. 6, pp. 874-887.e6
Open Access | Times Cited: 97
Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment
Giulia Petroni, Aitziber Buqué, Lisa M. Coussens, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 6, pp. 440-462
Closed Access | Times Cited: 96
Uridine-derived ribose fuels glucose-restricted pancreatic cancer
Zeribe C. Nwosu, Matthew H. Ward, Peter Sajjakulnukit, et al.
Nature (2023) Vol. 618, Iss. 7963, pp. 151-158
Open Access | Times Cited: 80
NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer
Tommy Weiss‐Sadan, Maolin Ge, Makiko Hayashi, et al.
Cell Metabolism (2023) Vol. 35, Iss. 3, pp. 487-503.e7
Open Access | Times Cited: 75
Next batter up! Targeting cancers with KRAS-G12D mutations
Mara N. Zeissig, Lauren M. Ashwood, Olga Kondrashova, et al.
Trends in cancer (2023) Vol. 9, Iss. 11, pp. 955-967
Open Access | Times Cited: 43
Cancer cell metabolism and antitumour immunity
Mara De Martino, Jeffrey C. Rathmell, Lorenzo Galluzzi, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 9, pp. 654-669
Open Access | Times Cited: 41
Targeting KRAS: from metabolic regulation to cancer treatment
Yanyan Shi, Huiling Zheng, Tianzhen Wang, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Hyaluronic acid fuels pancreatic cancer cell growth
Peter K. Kim, Christopher J. Halbrook, Samuel A. Kerk, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 75
Targeting KRAS in pancreatic cancer: new drugs on the horizon
Sahar F. Bannoura, Md. Hafiz Uddin, Misako Nagasaka, et al.
Cancer and Metastasis Reviews (2021) Vol. 40, Iss. 3, pp. 819-835
Open Access | Times Cited: 71
LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma
Zhencong Chen, Zhengyang Hu, Qihai Sui, et al.
International Journal of Biological Sciences (2021) Vol. 18, Iss. 2, pp. 522-535
Open Access | Times Cited: 68
O-GlcNAcylation promotes pancreatic tumor growth by regulating malate dehydrogenase 1
Qiang Zhu, Hong Zhou, Liming Wu, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 10, pp. 1087-1095
Closed Access | Times Cited: 63
Metabolic requirement for GOT2 in pancreatic cancer depends on environmental context
Samuel A. Kerk, Lin Lin, Amy L. Myers, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 50
A T Cell‐Engaging Tumor Organoid Platform for Pancreatic Cancer Immunotherapy
Zhuolong Zhou, Kevin Van der Jeught, Yujing Li, et al.
Advanced Science (2023) Vol. 10, Iss. 23
Open Access | Times Cited: 25
PRMT1 promotes pancreatic cancer development and resistance to chemotherapy
Bomin Ku, David Eisenbarth, Seonguk Baek, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 3, pp. 101461-101461
Open Access | Times Cited: 14
Oncogenic KRAS induces arginine auxotrophy and confers a therapeutic vulnerability to SLC7A1 inhibition in non-small cell lung cancer
Xiameng Gai, Yingluo Liu, Xiaojing Lan, et al.
Cancer Research (2024) Vol. 84, Iss. 12, pp. 1963-1977
Closed Access | Times Cited: 13
Artificial Intelligence Applications in the Treatment of Colorectal Cancer: A Narrative Review
Jiaqing Yang, Jing Huang, Deqian Han, et al.
Clinical Medicine Insights Oncology (2024) Vol. 18
Open Access | Times Cited: 10
Barriers and opportunities in pancreatic cancer immunotherapy
Yixin Ju, Dongzhi Xu, Miao-Miao Liao, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 9
Impact of KRAS mutation on the tumor microenvironment in colorectal cancer
Yiru Zhou, Yeye Kuang, Chan Wang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 5, pp. 1947-1964
Open Access | Times Cited: 8
Reprogramming of glucose metabolism: The hallmark of malignant transformation and target for advanced diagnostics and treatments
Qing Tang, Siqi Wu, Baiming Zhao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117257-117257
Open Access | Times Cited: 8
Resistance looms for KRAS G12C inhibitors and rational tackling strategies
Junmin Zhang, Jilei Zhang, Qing Liu, et al.
Pharmacology & Therapeutics (2021) Vol. 229, pp. 108050-108050
Closed Access | Times Cited: 44
Single-cell dissection of remodeled inflammatory ecosystem in primary and metastatic gallbladder carcinoma
Xiang Wang, Chunliang Liu, Jianan Chen, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top